SYNTHETIC RECORD, NOT A REAL MEDICAL RECORD — Richard Roundtree Synthetic CCD

PatientRichard Roundtree
Date of birth1975-07-09
IdentifiersMRN HR-ML015-SYN; SSN (made up) 000-15-8410
Document date2026-11-01
AuthorLeon Carrington, MD
CustodianSt. Posthumous Health Center

Readable copy of the C-CDA narrative, generated with the XML. Coded entries are in the XML file beside this page.

Reason for Visit

New painless lump under the left nipple in a man of 51. Concerns: Found a small, painless lump under the left nipple in the shower a few days ago; at first put it down to the breast enlargement he had at 13; Embarrassed to bring up a breast lump and did not think a man could have breast cancer; worried that a diagnosis could cost him work and wants it kept private. [S]

Allergies and Intolerances

AllergyReactionStatusEvidence
No known allergyactiveS

Medications

MedicationFrequencyRouteDatesStatusEvidence
Acetaminophen 500 mg oral tablet, two tablets by mouth every 6 hours as needed for pain after surgery, no more than 3 g a dayTwo tablets every 6 hours as neededOral route2026-10-07 to 2026-10-17completedS

Procedures

ProcedureDatesStatusEvidence
Diagnostic mammography of both breasts: 1.6 cm irregular, spiculated retroareolar mass eccentric to the left nipple (BI-RADS 5); right breast with no mass and no gynecomastia (BI-RADS 1)2026-09-30 to 2026-09-30completedS
Ultrasound of both breasts and both axillae: 1.5 cm irregular hypoechoic mass with angular margins next to the left nipple; one left axillary lymph node with a thickened cortex; right breast and right axilla normal2026-09-30 to 2026-09-30completedS
Ultrasound-guided core needle biopsy of the left breast mass and the left axillary node: invasive ductal carcinoma, grade 3; estrogen receptor 95 percent, progesterone receptor 85 percent, HER2 1+ (negative), Ki-67 30 percent; the node contains metastatic carcinoma2026-09-30 to 2026-09-30completedS
Mastectomy with level I and II axillary lymph node dissection for left breast cancer. Pathology of the left breast: invasive ductal carcinoma 1.6 cm, grade 3, margins clear, no lymphovascular invasion; 2 of 15 lymph nodes involved (largest 7 mm), no extranodal extension; pT1c pN1a, stage IIA2026-10-07 to 2026-10-07completedS
Transthoracic echocardiogram before anthracycline chemotherapy: left ventricular ejection fraction 62 percent; normal valves and wall motion2026-10-23 to 2026-10-23completedS
Advance care planning conversation, about 20 minutes2026-10-27 to 2026-10-27completedS

Immunizations

DateVaccineStatusEvidence
2021-06-15Tdap vaccinecompletedS
2026-10-27Influenza vaccine, 2026-2027 season (inactivated)completedS
2026-10-27COVID-19 mRNA vaccine, 2026-2027 formulacompletedS
2026-10-27Pneumococcal conjugate vaccine PCV20completedS

Past Medical History

Historical biography with true dates. These events are not part of the synthetic care timeline.

Historical dateHistoryEvidence
About 1955 (age 13)Breast enlargement (gynecomastia) at 13, which he described as due to a hormonal imbalance and as common in boys; no treatment recordedD (CLM-0003)

Family History

No family medical history is documented in the logged sources. Family history of real relatives is recorded only from documented or retrospective sources and is never synthesized.

Health Concerns

ConcernStatusEvidence
Found a small, painless lump under the left nipple in the shower a few days ago; at first put it down to the breast enlargement he had at 13activeS
Embarrassed to bring up a breast lump and did not think a man could have breast cancer; worried that a diagnosis could cost him work and wants it kept privateactiveS

Assessment

Most recent measures: Patient Health Questionnaire 2 item (PHQ-2) total score [Reported] 1 on 2026-10-27; Hemoglobin [Mass/volume] in Blood 13.9 on 2026-10-20; Leukocytes [#/volume] in Blood by Automated count 7 on 2026-10-20; Neutrophils [#/volume] in Blood by Automated count 4.3 on 2026-10-20; Platelets [#/volume] in Blood by Automated count 281 on 2026-10-20; Sodium [Moles/volume] in Serum or Plasma 139 on 2026-10-05; Potassium [Moles/volume] in Serum or Plasma 4.1 on 2026-10-05; Creatinine [Mass/volume] in Serum or Plasma 0.98 on 2026-10-20; Glomerular filtration rate [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI 2021)/1.73 sq M 93 on 2026-10-20; Glucose [Mass/volume] in Serum or Plasma 92 on 2026-10-05; Calcium [Mass/volume] in Serum or Plasma 9.5 on 2026-10-05; Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma 21 on 2026-10-20; Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma 22 on 2026-10-05; Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma 71 on 2026-10-05; Bilirubin.total [Mass/volume] in Serum or Plasma 0.6 on 2026-10-20; Albumin [Mass/volume] in Serum or Plasma 4.3 on 2026-10-20; Patient Health Questionnaire 9 item (PHQ-9) total score [Reported] 6 on 2026-10-20; Total score [AUDIT-C] 2 on 2026-10-27; Cholesterol [Mass/volume] in Serum or Plasma 186 on 2026-10-27; Cholesterol in HDL [Mass/volume] in Serum or Plasma 56 on 2026-10-27; Cholesterol in LDL [Mass/volume] in Serum or Plasma by calculation 112 on 2026-10-27; Triglyceride [Mass/volume] in Serum or Plasma 90 on 2026-10-27; Hemoglobin A1c/Hemoglobin.total in Blood 5.3 on 2026-10-27 [S]

Strengths and supports: Supports: close friends and family; wants the diagnosis kept private for now [S]

Problems

ProblemClinical statusVerificationCodeProvenance
Invasive ductal carcinoma of the left male breast, central (retroareolar) portion, presenting as a 1.5 cm firm, painless lump eccentric to the left nipple with a palpable left axillary node; core biopsy: grade 3, ER positive, PR positive, HER2 negative, with metastatic carcinoma in the node; clinical stage IIA (cT1c cN1 M0); synthetic modern detail linked to his publicly disclosed breast canceractiveconfirmed C50.122S — Synthetic size, grade, receptor status, and stage; the left-sided lump, the operation, and the spread to lymph nodes are from his public account (D).
Estrogen receptor-positive status of the breast canceractiveconfirmed Z17.0S — Synthetic receptor result; his tumor biology was not made public.
New firm, painless lump of about 1.5 cm just off the left nipple, with a palpable left axillary node; suspected breast cancer, imaging and core biopsy bookedresolvedconfirmed N63.42S — Synthetic presenting concern at the index visit, superseded by the biopsy diagnosis; the left-sided lump is from his public account (D).

Results

DateMeasureValueUnitReference rangeFlagProvenance
2026-09-29Patient Health Questionnaire 2 item (PHQ-2) total score [Reported]1{score}S
2026-10-05Hemoglobin [Mass/volume] in Blood14.8g/dL13.2-16.6 g/dLNormalS
2026-10-05Leukocytes [#/volume] in Blood by Automated count6.610*3/uL4-11 10*3/uLNormalS
2026-10-05Neutrophils [#/volume] in Blood by Automated count3.910*3/uL1.5-7.7 10*3/uLNormalS
2026-10-05Platelets [#/volume] in Blood by Automated count24610*3/uL150-400 10*3/uLNormalS
2026-10-05Sodium [Moles/volume] in Serum or Plasma139mmol/L135-145 mmol/LNormalS
2026-10-05Potassium [Moles/volume] in Serum or Plasma4.1mmol/L3.5-5.1 mmol/LNormalS
2026-10-05Creatinine [Mass/volume] in Serum or Plasma1.02mg/dL0.74-1.35 mg/dLNormalS
2026-10-05Glomerular filtration rate [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI 2021)/1.73 sq M89mL/min/{1.73_m2}>=60 mL/min/1.73 m²NormalS
2026-10-05Glucose [Mass/volume] in Serum or Plasma92mg/dL70-99 mg/dLNormalS
2026-10-05Calcium [Mass/volume] in Serum or Plasma9.5mg/dL8.6-10.3 mg/dLNormalS
2026-10-05Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma24U/L7-55 U/LNormalS
2026-10-05Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma22U/L8-48 U/LNormalS
2026-10-05Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma71U/L40-129 U/LNormalS
2026-10-05Bilirubin.total [Mass/volume] in Serum or Plasma0.7mg/dL0.1-1.2 mg/dLNormalS
2026-10-05Albumin [Mass/volume] in Serum or Plasma4.4g/dL3.5-5 g/dLNormalS
2026-10-05Patient Health Questionnaire 9 item (PHQ-9) total score [Reported]5{score}S
2026-10-20Hemoglobin [Mass/volume] in Blood13.9g/dL13.2-16.6 g/dLNormalS
2026-10-20Leukocytes [#/volume] in Blood by Automated count710*3/uL4-11 10*3/uLNormalS
2026-10-20Neutrophils [#/volume] in Blood by Automated count4.310*3/uL1.5-7.7 10*3/uLNormalS
2026-10-20Platelets [#/volume] in Blood by Automated count28110*3/uL150-400 10*3/uLNormalS
2026-10-20Creatinine [Mass/volume] in Serum or Plasma0.98mg/dL0.74-1.35 mg/dLNormalS
2026-10-20Glomerular filtration rate [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI 2021)/1.73 sq M93mL/min/{1.73_m2}>=60 mL/min/1.73 m²NormalS
2026-10-20Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma21U/L7-55 U/LNormalS
2026-10-20Bilirubin.total [Mass/volume] in Serum or Plasma0.6mg/dL0.1-1.2 mg/dLNormalS
2026-10-20Albumin [Mass/volume] in Serum or Plasma4.3g/dL3.5-5 g/dLNormalS
2026-10-20Patient Health Questionnaire 9 item (PHQ-9) total score [Reported]6{score}S
2026-10-27Patient Health Questionnaire 2 item (PHQ-2) total score [Reported]1{score}S
2026-10-27Total score [AUDIT-C]2{score}S
2026-10-27Cholesterol [Mass/volume] in Serum or Plasma186mg/dL<=200 mg/dLNormalS
2026-10-27Cholesterol in HDL [Mass/volume] in Serum or Plasma56mg/dL>=40 mg/dLNormalS
2026-10-27Cholesterol in LDL [Mass/volume] in Serum or Plasma by calculation112mg/dL<=129 mg/dLNormalS
2026-10-27Triglyceride [Mass/volume] in Serum or Plasma90mg/dL<=149 mg/dLNormalS
2026-10-27Hemoglobin A1c/Hemoglobin.total in Blood5.3%<=5.6%NormalS

Social History

Vital Signs

DateMeasureValueUnitProvenance
2026-09-29Body height188cmS
2026-09-29Body weight86kgS
2026-09-29Body mass index (BMI) [Ratio]24.3kg/m2S
2026-09-29Systolic blood pressure128mm[Hg]S
2026-09-29Diastolic blood pressure80mm[Hg]S
2026-09-29Heart rate74/minS
2026-09-29Respiratory rate14/minS
2026-09-29Body temperature36.7CelS
2026-09-29Oxygen saturation in Arterial blood by Pulse oximetry99%S
2026-10-05Body height188cmS
2026-10-05Body weight85.6kgS
2026-10-05Body mass index (BMI) [Ratio]24.2kg/m2S
2026-10-05Systolic blood pressure134mm[Hg]S
2026-10-05Diastolic blood pressure82mm[Hg]S
2026-10-05Heart rate82/minS
2026-10-05Respiratory rate16/minS
2026-10-05Body temperature36.8CelS
2026-10-05Oxygen saturation in Arterial blood by Pulse oximetry99%S
2026-10-20Body height188cmS
2026-10-20Body weight84.8kgS
2026-10-20Body mass index (BMI) [Ratio]24kg/m2S
2026-10-20Systolic blood pressure126mm[Hg]S
2026-10-20Diastolic blood pressure78mm[Hg]S
2026-10-20Heart rate76/minS
2026-10-20Respiratory rate14/minS
2026-10-20Body temperature36.7CelS
2026-10-20Oxygen saturation in Arterial blood by Pulse oximetry99%S
2026-10-27Body height188cmS
2026-10-27Body weight85kgS
2026-10-27Body mass index (BMI) [Ratio]24kg/m2S
2026-10-27Systolic blood pressure124mm[Hg]S
2026-10-27Diastolic blood pressure78mm[Hg]S
2026-10-27Heart rate72/minS
2026-10-27Respiratory rate14/minS
2026-10-27Body temperature36.6CelS
2026-10-27Oxygen saturation in Arterial blood by Pulse oximetry99%S

Encounters

DatePurposeStatusProvenance
2026-09-29New painless lump under the left nipple in a man of 51finishedS
2026-10-05Biopsy results: breast cancer; surgical oncology consultation; germline test and preparation for surgeryfinishedS
2026-10-20Review two weeks after mastectomy and axillary dissection: pathology, wound and arm care, and preparation for chemotherapyfinishedS
2026-10-27Periodic adult preventive visit before chemotherapyfinishedS

Plan of Treatment

InterventionStatusGuidelineProvenance
Urgent surgical oncology (breast) consultation for a suspected breast cancer with an abnormal left axillary node, core biopsy pending, to plan the operation and the axillacompletedGL-ASCO-MBC-2020, GL-NCCN-BREAST-2025S
Same-week diagnostic mammography and ultrasound of both breasts and both axillae, and ultrasound-guided core biopsy of the mass and the abnormal node with ER, PR, and HER2 testingcompletedGL-ASCO-MBC-2020, GL-NCCN-BREAST-2025S
Genetic counseling and germline multigene panel testing (including BRCA2, BRCA1, PALB2, CHEK2, and ATM), as for every man with breast cancer, with a letter for relatives if a variant is foundcompletedGL-ASCO-MBC-2020, GL-ASCO-SSO-GERM-2024S
Mastectomy with axillary lymph node dissection, then shoulder exercises and lymphedema risk reduction with arm measurements at each visitcompletedGL-NCCN-BREAST-2025, GL-ACS-ASCO-SURV-2016S
Adjuvant chemotherapy given by medical oncology (doxorubicin and cyclophosphamide every three weeks for four cycles, then weekly paclitaxel for twelve weeks, about six months), after a baseline echocardiogram, hepatitis B screening, vaccines, and a dental review; radiation oncology review of post-mastectomy radiation after chemotherapycompletedGL-NCCN-BREAST-2025, GL-ASCO-CARDIO-2017, GL-ASCO-HBV-2020S
Tamoxifen after chemotherapy for at least five years, the first-choice endocrine therapy for men, with venous thromboembolism, mood, hot flash, sexual side effect, and adherence checks at every visitcompletedGL-ASCO-MBC-2020, GL-CMID-2026S
Distress screening at each visit, plain information that men get breast cancer, confidential handling of his diagnosis at work, and the offer of a peer-support group for men with breast cancercompletedGL-ACS-ASCO-SURV-2016, GL-CMID-2026S

Goals

GoalTargetStatusOutcomeProvenance
Tissue diagnosis within one week of presentation2026-10-05completedImaging and core biopsy the day after presentation; diagnosis explained on the sixth dayS
Curative surgery within two weeks of diagnosis, with lymphedema prevention taught2026-10-20completedMastectomy and axillary dissection two days after the diagnosis; clear margins; arm exercises and risk reduction taughtS
Complete germline genetic testing with counseling before chemotherapy starts2026-10-27activePanel sent on the day of diagnosis; result not yet back at the end of the episodeS
Be ready to start adjuvant chemotherapy within six weeks of surgery: echocardiogram, hepatitis B screening, vaccines, and dental review done2026-10-27activeEchocardiogram normal; vaccines and hepatitis B screening at the preventive visit; dental review booked; first cycle scheduledS

Functional Status

Mental Status